This is a preview of subscription content, log in via an institution to check access.
Notes
CLinical Evaluation Of Pertuzumab And TRAstuzumab, funded by Hoffmann-La Roche Ltd, Switzerland
Functional Assessment of Cancer Therapy-Breast
Reference
Cortes J, et al. Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. Annals of Oncology : 17 Jul 2013. Available from: URL: http://dx.doi.org/10.1093/annonc/mdt274
Rights and permissions
About this article
Cite this article
Pertuzumab prolongs survival in MBC, no adverse effect on QOL. PharmacoEcon Outcomes News 684, 9 (2013). https://doi.org/10.1007/s40274-013-0616-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0616-y